A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer
European Journal of Cancer · 2024-05 · 202 · 114007
DOI: 10.1016/j.ejca.2024.114007 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2024-05. Verfasst von Ulka N Vaishampayan und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Bridged-Ring Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Michigan Ann Arbor, MI, USA.
- Modra Pharmaceuticals B.V., Amsterdam, Netherlands. Electronic address: mariannekeessen@gmail.com.
- University of Virginia, Charlottesville, VA, USA.
- Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
- Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
- Debrecen Institute of Oncology, Debrecen, Hungary.
Zitieren
APA
Vaishampayan, U. N., Keessen, M., Dreicer, R., Heath, E. I., Buchler, T., Árkosy, P. F., Csöszi, T., Wiechno, P., Kopyltsov, E., Orlov, S. V., Plekhanov, A., Smagina, M., Varlamov, S., & Shore, N. D. (2024). A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer. European Journal of Cancer, 202, 114007. https://doi.org/10.1016/j.ejca.2024.114007
Vancouver
Vaishampayan UN, Keessen M, Dreicer R, Heath EI, Buchler T, Árkosy PF, et al. A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer. European Journal of Cancer. 2024;202:114007. doi:10.1016/j.ejca.2024.114007
BibTeX
@article{Vaishampayan2024,
author = {Vaishampayan, Ulka N and Keessen, Marianne and Dreicer, Robert and Heath, Elisabeth I and Buchler, Tomas and Árkosy, Péter F and Csöszi, Tibor and Wiechno, Pawel and Kopyltsov, Evgeny and Orlov, Sergey V and Plekhanov, Alexey and Smagina, Maria and Varlamov, Sergei and Shore, Neal D},
title = {A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer},
journal = {European Journal of Cancer},
year = {2024},
volume = {202},
pages = {114007},
doi = {10.1016/j.ejca.2024.114007}
}
EUVIMED